全球原代细胞市场 – 行业趋势及 2029 年预测

 原代细胞市场分析及规模

由于老年人口不断增长、慢性病病例不断增加以及研发的进步，原代细胞培养市场正在经历增长。全球制药市场正在吸引大量投资于先进的药物开发和测试。

Data Bridge Market Research 分析，2021 年原代细胞市场规模为 12.4 亿美元，预计到 2029 年将达到 29.2 亿美元，2022 年至 2029 年预测期内的复合年增长率为 11.30%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

原代细胞市场范围和细分      

市场定义

Primary cells refer to cells taken directly from living tissues of animals or humans and are then processed to establish them for use in appropriate cell therapies. Primary cells are widely used in various applications, including 3D cell culture, virology, cancer research, stem cell therapy, and tissue replacement. Researchers are increasingly using the 3D cell culture product to study cell biology and biochemistry, drug effects, cell signaling, and cell-pathogen interactions. The pharmaceutical industry uses the product to investigate drug cytotoxicity, produce biomolecules, and develop vaccines. The use of primary cells eliminates the need for animal models in vaccine development. Viruses can be detected and isolated to determine the mode of infection using primary cells.

Global Primary Cells Market Dynamics

Drivers

• Robust Investments into Research and Development (R&D)

Significant investments in R&D activities are rapidly driving the global market for primary cells to develop effective therapies in which primary cells can be used to treat various immunodeficiency disorders. Because of the growth of the biotechnology and biopharmaceutical industries, medical researchers are constantly working on using primary cells from animal or human tissue to treat malignant cancers. Furthermore, the use of patient-derived specimens in innovative preclinical technologies, such as 3D cell cultures, is driving the growth of the primary cell market. Furthermore, the use of human primary cells is increasingly becoming a preferred choice for studying the effects of cancer cells on the human body without using animal cells.

• Rising Cases of Cancers

The consistent growth in the global market for primary cells can be linked to the increasing occurrence of cancers around the world. Primary cells are used for cancer cell discovery and drug screening due to their superiority over cell lines, which is fuelling market growth. Furthermore, primary cells are used in extensive research activities to develop relevant therapies and techniques, such as cell therapies and regenerative therapies, to treat cancer patients; because cancer is recognized as the leading cause of death worldwide, governments and private institutes all over the world are rapidly investing in advanced healthcare technologies for effective cancer treatment, providing impetus to the primary cell market growth.

Opportunities

• Drug Screening and Toxicity Testing

To investigate the cytotoxicity of new drugs, primary cell cultures are used. It is useful for industrial-scale synthesis or production of a wide range of biomolecules. This is especially helpful in the pharmaceutical industry. Several research projects on cell-based therapeutic products based on primary cells are currently being developed. Primary culture is used instead of animal models to test the effects of new drugs, cosmetics, and chemicals. They are also used to calculate the maximum allowable dosage of new drugs. These are some of the factors expected to propel the market's growth.

Restraints/Challenges

• Concerns Regarding Primary Cell Culture Contamination

Cell contamination is one of the major problems in cell culture laboratories. Using contaminated cells endangers physiology, leads to incorrect results, and causes loss of unique cell lines.

This primary cells market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the primary cells market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Primary Cells Market

According to the WHO, 70 vaccine under development and 3 are already in human trials. The pandemic's economic and social burden has prompted global government bodies to increase support for vaccine development, which has led to increased adoption rates of primary cells for COVID-19 research.

Recent developments

• In March 2021, Axol Bioscience Ltd., a global leader in the market for primary cells, recently announced a merger with Censo Biotechnologies. The merged company is focused on providing product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets.

Global Primary Cells Market Scope

The primary cells market is segmented on the basis of type, origin, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Animal Primary Cells
• Human Primary Cells
• Others

Origin

• Dermatocytes
• Gastrointestinal Cells
• Heart Cells
• Hematopoietic Cells
• Hepatocytes
• Cryopreserved hepatocytes
•  Fresh hepatocytes
• Lung Cells
• Musculoskeletal Cells
• Renal Cells
• Others

End User

• Life Science Research Companies
• Research Institutes

Primary Cells Market Regional Analysis/Insights

对原代细胞市场进行了分析，并按国家、类型、原产地和最终用户提供了市场规模洞察和趋势，如上所述。

原电池市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于政府对研究的资助不断增加、该地区癌症发病率不断上升以及技术进步，北美在原代细胞市场占据主导地位。

由于人均医疗支出不断增加以及老年人口基数不断上升，预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

原代细胞市场还为您提供每个国家/地区资本设备医疗支出增长、原代细胞市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对原代细胞市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和原代细胞市场份额分析

原代细胞市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对原代细胞市场的关注有关。

原代细胞市场的一些主要参与者包括：

• 赛默飞世尔科技公司（美国）
• 默克集团（德国）
• 龙沙（瑞士）
• Cell Biologics, Inc.（美国）
• PromoCell - 以人为本的科学（德国）
• ZenBio, Inc.（美国）
• STEMCELL Technologies Inc（加拿大）
• AllCells（美国）
• ATCC（美国）
• Axol Bioscience（英国）
• ReachBio 研究实验室（美国）
• Charles River Laboratories（美国）
• Creative Bioray（美国）
• PELOBIOTECH GmbH（德国）
• Sigma-Aldrich 公司（美国）

研究方法：全球原代细胞市场

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。 

SKU-56543